Oncomed Pharmaceuticals Inc Sets New 1-Year High at $33.25 (OMED)
Oncomed Pharmaceuticals (NASDAQ:OMED)’s share price reached a new 52-week high during trading on Wednesday, Analyst RN reports. The stock traded as high as $33.25 and last traded at $31.84, with a volume of 289,439 shares traded. The stock had previously closed at $31.18.
Separately, analysts at Jefferies Group raised their price target on shares of Oncomed Pharmaceuticals from $27.00 to $46.00 in a research note to investors on Wednesday, December 4th. They now have a “buy” rating on the stock.
Oncomed Pharmaceuticals has a 52-week low of $12.07 and a 52-week high of $32.39. The stock’s 50-day moving average is $23.92 and its 200-day moving average is $18.79. The company’s market cap is $882.5 million.
Oncomed Pharmaceuticals (NASDAQ:OMED) last released its earnings data on Tuesday, November 12th. The company reported ($0.15) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.12 by $0.27. Analysts expect that Oncomed Pharmaceuticals will post $-0.68 EPS for the current fiscal year.
OncoMed Pharmaceuticals, Inc (NASDAQ:OMED) is a clinical development-stage biopharmaceutical company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.